CZ194994A3 - Piperazine and piperidine derivatives, process of their preparation and pharmaceutical compositions containing thereof - Google Patents

Piperazine and piperidine derivatives, process of their preparation and pharmaceutical compositions containing thereof Download PDF

Info

Publication number
CZ194994A3
CZ194994A3 CZ941949A CZ194994A CZ194994A3 CZ 194994 A3 CZ194994 A3 CZ 194994A3 CZ 941949 A CZ941949 A CZ 941949A CZ 194994 A CZ194994 A CZ 194994A CZ 194994 A3 CZ194994 A3 CZ 194994A3
Authority
CZ
Czechia
Prior art keywords
formula
group
compound
piperazinyl
butyl
Prior art date
Application number
CZ941949A
Other languages
Czech (cs)
English (en)
Inventor
Mark Henry Norman
Frank Navas Iii
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of CZ194994A3 publication Critical patent/CZ194994A3/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
CZ941949A 1992-02-12 1993-02-11 Piperazine and piperidine derivatives, process of their preparation and pharmaceutical compositions containing thereof CZ194994A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929202915A GB9202915D0 (en) 1992-02-12 1992-02-12 Chemical compounds

Publications (1)

Publication Number Publication Date
CZ194994A3 true CZ194994A3 (en) 1995-09-13

Family

ID=10710223

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ941949A CZ194994A3 (en) 1992-02-12 1993-02-11 Piperazine and piperidine derivatives, process of their preparation and pharmaceutical compositions containing thereof

Country Status (16)

Country Link
EP (1) EP0625978A1 (ko)
JP (1) JPH07503723A (ko)
KR (1) KR950700290A (ko)
AU (1) AU3460393A (ko)
CA (1) CA2117434A1 (ko)
CZ (1) CZ194994A3 (ko)
FI (1) FI943718A (ko)
GB (1) GB9202915D0 (ko)
HU (1) HUT72309A (ko)
IL (1) IL104690A0 (ko)
MX (1) MX9300786A (ko)
NO (1) NO942977L (ko)
RU (1) RU94038064A (ko)
SK (1) SK96494A3 (ko)
WO (1) WO1993016073A1 (ko)
ZA (1) ZA93958B (ko)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776963A (en) * 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
US5364866A (en) * 1989-05-19 1994-11-15 Hoechst-Roussel Pharmaceuticals, Inc. Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
RU2118322C1 (ru) * 1993-07-05 1998-08-27 Дюфар Интернэшнл Рисерч Б.В. 2,3-дигидро-1,4-бензодиокси-5-ил-пиперазиновые производные или их соли
JPH0912562A (ja) * 1995-06-22 1997-01-14 Suntory Ltd 置換ベンゾチアジン誘導体
US6001827A (en) * 1993-12-24 1999-12-14 Suntory Limited Benzothiazine derivative
US5874429A (en) * 1993-12-24 1999-02-23 Suntory Limited Benzothiazine derivative
DE69433005T2 (de) * 1993-12-24 2004-06-09 Daiichi Suntory Pharma Co., Ltd. Benzothiazinderivate
JP3948744B2 (ja) * 1994-11-04 2007-07-25 大日本住友製薬株式会社 新規なラクタム誘導体
EP0732332B1 (en) * 1995-03-17 2001-12-19 Aventis Pharmaceuticals Inc. Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation
US6087364A (en) * 1998-01-29 2000-07-11 Warner-Lambert Company Dopamine D4 receptor antagonists
DE19814084B4 (de) 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
CA2363942A1 (en) * 1999-04-06 2000-10-12 Sepracor Inc. Methods and compositions for the treatment of psychotic and related disorders using ziprasidone metabolites
US7030142B1 (en) 1999-04-06 2006-04-18 Sepracor Inc. Methods for the treatment of neuroleptic and related disorders using ziprasidone metabolites
AR028685A1 (es) * 2000-06-14 2003-05-21 Lundbeck & Co As H Derivados de indol
US8246980B2 (en) 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system
DE10234673B4 (de) 2002-07-30 2007-08-16 Schwarz Pharma Ag Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
US8246979B2 (en) 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system for the administration of rotigotine
US9174975B2 (en) 2002-08-22 2015-11-03 Sumitomo Dainippon Pharma Co., Ltd Remedy for integration dysfunction syndrome
DE10261696A1 (de) 2002-12-30 2004-07-15 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
CA2531980C (en) 2003-06-23 2013-09-17 Dainippon Sumitomo Pharma Co., Ltd. Imide derivatives as therapeutic agents for senile dementia
DE10334188B4 (de) 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
WO2005080976A1 (ja) 2004-02-20 2005-09-01 Dainippon Sumitomo Pharma Co., Ltd. 統合失調症の記憶・学習機能障害治療薬のin vivoスクリーニング方法
EP2114158B1 (en) * 2007-01-03 2012-08-08 Cortex Pharmaceuticals, Inc. 3-substituted-[1,2,3]benzotriazinone compounds for enhancing glutamatergic synaptic responses
US8258139B2 (en) 2010-11-08 2012-09-04 Dainippon Sumitomo Pharma Co., Ltd. Method of treatment for mental disorders
GB201102248D0 (en) 2011-02-09 2011-03-23 Isis Innovation Treatment of bipolar disorder
US8981095B2 (en) 2011-07-28 2015-03-17 Mapi Pharma Ltd. Intermediate compounds and process for the preparation of lurasidone and salts thereof
SG11201600743WA (en) * 2013-07-31 2016-02-26 Merck Patent Gmbh Oxoquinazolinyl-butanamide derivatives
CN105669665A (zh) * 2016-03-15 2016-06-15 烟台贝森医药科技有限公司 哌罗匹隆的制备方法
WO2018035046A1 (en) 2016-08-15 2018-02-22 President And Fellows Of Harvard College Treating infections using idsd from proteus mirabilis
CN115124464B (zh) * 2022-07-04 2023-06-06 新乡学院 一种喹啉二酮磺酰哌嗪杂合体及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2258843B1 (ko) * 1974-01-30 1977-09-09 Roussel Uclaf
US4335127A (en) * 1979-01-08 1982-06-15 Janssen Pharmaceutica, N.V. Piperidinylalkyl quinazoline compounds, composition and method of use
JPH0625181B2 (ja) * 1985-03-27 1994-04-06 住友製薬株式会社 新規なイミド誘導体
AU593194B2 (en) * 1986-09-26 1990-02-01 Sumitomo Pharmaceuticals Company, Limited Imide derivatives ,and their production and use
CA1335289C (en) * 1987-10-26 1995-04-18 Fujio Antoku Piperidinyl benzisoxazole derivatives, their production and pharmaceutical use
US5001130A (en) * 1988-02-18 1991-03-19 Bristol-Myers Company Psychotropic heterobicycloalkylpiperazine derivatives
US4780466A (en) * 1988-03-17 1988-10-25 Hoechst-Roussel Pharmaceuticals, Inc. Arylpiperazinylalkoxy derivatives of cyclic imides
NZ230045A (en) * 1988-08-05 1990-11-27 Janssen Pharmaceutica Nv 3-piperazinylbenzazole derivatives and pharmaceutical compositions
US4968792A (en) * 1989-09-25 1990-11-06 American Home Products Corporation Psychotropic benzisothiazole derivatives
JP2800953B2 (ja) * 1990-07-06 1998-09-21 住友製薬株式会社 新規なイミド誘導体

Also Published As

Publication number Publication date
HU9402343D0 (en) 1994-10-28
JPH07503723A (ja) 1995-04-20
FI943718A0 (fi) 1994-08-11
RU94038064A (ru) 1997-05-27
HUT72309A (en) 1996-04-29
NO942977D0 (no) 1994-08-11
IL104690A0 (en) 1993-06-10
AU3460393A (en) 1993-09-03
CA2117434A1 (en) 1993-08-19
ZA93958B (en) 1994-08-11
FI943718A (fi) 1994-08-11
NO942977L (no) 1994-10-10
WO1993016073A1 (en) 1993-08-19
EP0625978A1 (en) 1994-11-30
KR950700290A (ko) 1995-01-16
GB9202915D0 (en) 1992-03-25
MX9300786A (es) 1994-03-31
SK96494A3 (en) 1995-07-11

Similar Documents

Publication Publication Date Title
CZ194994A3 (en) Piperazine and piperidine derivatives, process of their preparation and pharmaceutical compositions containing thereof
JP5208962B2 (ja) 二環式ピリミジノンおよびその使用
JP2656189B2 (ja) ベンゾイソチアゾールおよびベンゾイソキサゾール−3−カルボキサミド、その製法およびそれよりなる抗精神病剤
US20050171101A1 (en) Phenanthridinones as parp inhibitors
CZ17094A3 (en) BENZIMIDAZOLE DERIVATIVES AS 5-HT1a AND 5-HT2 ANTAGONISTS
JPWO2006051704A1 (ja) イミン化合物
JP2008539220A (ja) バソプレシンアンタゴニストとしてのトリアゾール誘導体
JPH06508366A (ja) イミダゾ〔1,5−a〕キノキサリン
JP4704755B2 (ja) 抗菌剤
BRPI0707028A2 (pt) método para alcaçar um efeito em um paciente, composto e composição farmacêutica
JP2013544256A (ja) 複素環式アミンおよびその使用
JP2003321472A (ja) Grk阻害剤
Hussenether et al. Clozapine derived 2, 3-dihydro-1H-1, 4-and 1, 5-benzodiazepines with D4 receptor selectivity: synthesis and biological testing
AU2013329097A1 (en) Urea and amide derivatives of aminoalkylpiperazines and use thereof
CZ204495A3 (en) Heteroaromatic compounds exhibiting antipsychotic activity
CZ298906B6 (cs) Deriváty 1H-pyrido[3,4-b]indol-4-karboxamidu, zpusob jejich prípravy a jejich použití jako lécivo
WO1997003986A1 (fr) Composes fusionnes de triazole
AU608511B2 (en) Benzimidazolesulfonamides and imidazopyridine-sulfonamides, their preparation and their application as drugs
JPH07242666A (ja) 複素環化合物
JP2005097276A (ja) 縮合ピリミジン誘導体およびその用途
WO1994003439A1 (en) Antiproliferative tricyclic compounds
KR890001051B1 (ko) 융합된 방향족 옥사제피논 및 이의 황동족체
JPH09151186A (ja) 縮合トリアゾール化合物
HU195649B (en) Process for producing oxazepinone derivatives condensed with aromatic ring and their sulfur analogs